Log in

NYSE:LHLaboratory Corp. of America Stock Price, Forecast & News

-2.70 (-2.33 %)
(As of 04/5/2020 05:13 AM ET)
Today's Range
Now: $113.31
50-Day Range
MA: $159.39
52-Week Range
Now: $113.31
Volume923,668 shs
Average Volume1.47 million shs
Market Capitalization$11.03 billion
P/E Ratio13.55
Dividend YieldN/A
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides technology-enabled solutions, including a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with convenient and secure access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More
Laboratory Corp. of America logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.79 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services



Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$18.98 per share
Book Value$77.93 per share


Net Income$823.80 million


Market Cap$11.03 billion
Next Earnings Date5/5/2020 (Estimated)

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

How has Laboratory Corp. of America's stock been impacted by COVID-19 (Coronavirus)?

Laboratory Corp. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LH stock has decreased by 28.7% and is now trading at $113.31. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Laboratory Corp. of America?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 1 sell rating, 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Laboratory Corp. of America.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Laboratory Corp. of America.

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) posted its earnings results on Thursday, February, 13th. The medical research company reported $2.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.80 by $0.06. The medical research company earned $3 billion during the quarter, compared to analysts' expectations of $2.92 billion. Laboratory Corp. of America had a net margin of 7.13% and a return on equity of 15.37%. The business's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the business posted $2.52 earnings per share. View Laboratory Corp. of America's earnings history.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of $11.75-$12.15 for the period, compared to the Thomson Reuters consensus estimate of $11.97.

What price target have analysts set for LH?

12 Wall Street analysts have issued 1-year price objectives for Laboratory Corp. of America's stock. Their forecasts range from $149.00 to $220.00. On average, they expect Laboratory Corp. of America's share price to reach $190.82 in the next twelve months. This suggests a possible upside of 68.4% from the stock's current price. View analysts' price targets for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

News headlines about LH stock have trended very negative this week, according to InfoTrie. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Laboratory Corp. of America earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave media stories about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutLaboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a decrease in short interest in March. As of March 13th, there was short interest totaling 1,593,400 shares, a decrease of 6.8% from the February 27th total of 1,710,000 shares. Based on an average daily volume of 750,400 shares, the short-interest ratio is currently 2.1 days. Currently, 1.7% of the shares of the company are short sold. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Micron Technology (MU), Gilead Sciences (GILD), NVIDIA (NVDA), Amgen (AMGN), AbbVie (ABBV), Allergan (AGN), Bank of America (BAC) and Chipotle Mexican Grill (CMG).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the following people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $113.31.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $11.03 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Corp. of America employs 65,000 workers across the globe. View additional information about Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: What is Cost of Debt?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel